Back
Rhythm Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$96.05
Seasonality Move:
-15.19%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
Rhythm Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.76 | Sell |
| 20-day SMA: | 104.83 | Sell |
| 50-day SMA: | 106.27 | Sell |
| 200-day SMA: | 92.01 | Buy |
| 8-day EMA: | 92.3 | Buy |
| 20-day EMA: | 61.71 | Buy |
| 50-day EMA: | 31.53 | Buy |
| 200-day EMA: | 8.99 | Buy |
Rhythm Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 28.5 | Buy |
| Relative Strength Index (14 RSI): | 40.2 | Sell |
| Chaikin Money Flow: | -636828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.97 - 107.79) | Sell |
| Bollinger Bands (100): | (99.68 - 110.22) | Sell |
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals, Inc. Stock
Is Rhythm Pharmaceuticals, Inc. Stock a Buy?
-
Rhythm Pharmaceuticals, Inc. share price is 98.47 while RYTM 8-day simple moving average is 104.76, which is a Sell signal.
-
The stock price of RYTM is 98.47 while Rhythm Pharmaceuticals, Inc. 20-day SMA is 104.83, which makes it a Sell.
-
Rhythm Pharmaceuticals, Inc. 50-day simple moving average is 106.27 while RYTM share price is 98.47, making it a Sell technically.
-
RYTM stock price is 98.47 and Rhythm Pharmaceuticals, Inc. 200-day simple moving average is 92.01, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
20
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy or a Sell?
-
Rhythm Pharmaceuticals, Inc. stock is rated a SellThe current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $98.47. The Score for RYTM is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals, Inc. Stock Info
Market Cap:
6.6B
Price in USD:
98.47
Share Volume:
952.8K
Rhythm Pharmaceuticals, Inc. 52-Week Range
52-Week High:
122.20
52-Week Low:
45.91
Sell
20
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Rhythm Pharmaceuticals, Inc. Share Price Forecast
-
What is the Rhythm Pharmaceuticals, Inc. stock price today?The Rhythm Pharmaceuticals, Inc. stock price is 98.47 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals, Inc. is overvalued.
Is Rhythm Pharmaceuticals, Inc. Stock a Buy?
-
Rhythm Pharmaceuticals, Inc. share price is 98.47 while RYTM 8-day exponential moving average is 92.30, which is a Buy signal.
-
The stock price of RYTM is 98.47 while Rhythm Pharmaceuticals, Inc. 20-day EMA is 61.71, which makes it a Buy.
-
Rhythm Pharmaceuticals, Inc. 50-day exponential moving average is 31.53 while RYTM share price is 98.47, making it a Buy technically.
-
RYTM stock price is 98.47 and Rhythm Pharmaceuticals, Inc. 200-day simple moving average is 8.99, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals, Inc.
Is Rhythm Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $2.87 per share.
Technical Analysis of Rhythm Pharmaceuticals, Inc.
Should I short Rhythm Pharmaceuticals, Inc. stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 28.5, suggesting Rhythm Pharmaceuticals, Inc. is a Buy
-
Rhythm Pharmaceuticals, Inc. Relative Strength Index (RSI) is 40.2, which suggest Rhythm Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals, Inc. is (100.97 - 107.79), which suggest Rhythm Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals, Inc. is (99.68 - 110.22), which suggest Rhythm Pharmaceuticals, Inc. is a Sell
* Rhythm Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.